{"id":6986,"date":"2019-12-19T10:29:38","date_gmt":"2019-12-19T09:29:38","guid":{"rendered":"https:\/\/botanico.uclm.es\/en\/project\/trastuzumab-targeted-biodegradable-nanoparticles-for-enhanced-delivery-of-dasatinib-in-her2-metastasic-breast-cancer\/"},"modified":"2022-12-22T17:14:57","modified_gmt":"2022-12-22T16:14:57","slug":"trastuzumab-targeted-biodegradable-nanoparticles-for-enhanced-delivery-of-dasatinib-in-her2-metastasic-breast-cancer","status":"publish","type":"project","link":"https:\/\/botanico.uclm.es\/en\/project\/trastuzumab-targeted-biodegradable-nanoparticles-for-enhanced-delivery-of-dasatinib-in-her2-metastasic-breast-cancer\/","title":{"rendered":"Trastuzumab-targeted biodegradable nanoparticles for enhanced delivery of dasatinib in HER2+ metastasic breast cancer"},"content":{"rendered":"<style type=\"text\/css\"> \n#cmsms_row_69f6d260a8115 .cmsms_row_outer_parent { \n\tpadding-top: 0px; \n} \n\n#cmsms_row_69f6d260a8115 .cmsms_row_outer_parent { \n\tpadding-bottom: 50px; \n} \n\n<\/style><div id=\"cmsms_row_69f6d260a8115\" class=\"cmsms_row cmsms_color_scheme_default\">\n<div class=\"cmsms_row_outer_parent\">\n<div class=\"cmsms_row_outer\">\n<div class=\"cmsms_row_inner\">\n<div class=\"cmsms_row_margin\">\n<div class=\"cmsms_column one_first\">\n<div class=\"cmsms_text\">\n<h2 class=\"Heading\">Resumen<\/h2>\n<p>Dasatinib (DAS) is a multikinase inhibitor that acts on several signaling kinases. DAS is used as a second-line treatment for chronic accelerated myeloid and Philadelphia chromosomepositive acute lymphoblastic leukemia. The therapeutic potential of DAS in other solid tumours is under evaluation. As for many other compounds, an improvement in their pharmacokinetic and delivery properties would potential augment the efficacy. Antibody-targeted biodegradable nanoparticles can be useful in targeted cancer therapy. DAS has shown activity in human epidermal growth factor receptor 2 (HER2) positive tumors, so conjugation of this compound with the anti- HER2 antibody trastuzumab (TAB) with the use of nanocarriers could improve its efficacy. TABtargeted DAS-loaded nanoparticles were generated by nanotechnology. The guided nanocarriers enhanced in vitro cytotoxicity of DAS against HER2 human breast cancer cell lines. Cellular mechanistic, release studies and nanoparticles stability were undertaken to provide evidences for positioning DAS-loaded TAB-targeted nanoparticles as a potential strategy for further development in HER2-overexpressing breast cancer therapy. \u00a9 2019 by the authors. Licensee MDPI, Basel, Switzerland.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":0,"menu_order":0,"comment_status":"open","ping_status":"open","template":"","format":"standard","meta":[],"pj-categs":[74],"pj-tags":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v19.9 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Trastuzumab-targeted biodegradable nanoparticles for enhanced delivery of dasatinib in HER2+ metastasic breast cancer - Instituto Bot\u00e1nico<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/botanico.uclm.es\/en\/project\/trastuzumab-targeted-biodegradable-nanoparticles-for-enhanced-delivery-of-dasatinib-in-her2-metastasic-breast-cancer\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Trastuzumab-targeted biodegradable nanoparticles for enhanced delivery of dasatinib in HER2+ metastasic breast cancer - Instituto Bot\u00e1nico\" \/>\n<meta property=\"og:url\" content=\"https:\/\/botanico.uclm.es\/en\/project\/trastuzumab-targeted-biodegradable-nanoparticles-for-enhanced-delivery-of-dasatinib-in-her2-metastasic-breast-cancer\/\" \/>\n<meta property=\"og:site_name\" content=\"Instituto Bot\u00e1nico\" \/>\n<meta property=\"article:modified_time\" content=\"2022-12-22T16:14:57+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/botanico.uclm.es\/en\/project\/trastuzumab-targeted-biodegradable-nanoparticles-for-enhanced-delivery-of-dasatinib-in-her2-metastasic-breast-cancer\/\",\"url\":\"https:\/\/botanico.uclm.es\/en\/project\/trastuzumab-targeted-biodegradable-nanoparticles-for-enhanced-delivery-of-dasatinib-in-her2-metastasic-breast-cancer\/\",\"name\":\"Trastuzumab-targeted biodegradable nanoparticles for enhanced delivery of dasatinib in HER2+ metastasic breast cancer - Instituto Bot\u00e1nico\",\"isPartOf\":{\"@id\":\"https:\/\/botanico.uclm.es\/#website\"},\"datePublished\":\"2019-12-19T09:29:38+00:00\",\"dateModified\":\"2022-12-22T16:14:57+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/botanico.uclm.es\/en\/project\/trastuzumab-targeted-biodegradable-nanoparticles-for-enhanced-delivery-of-dasatinib-in-her2-metastasic-breast-cancer\/#breadcrumb\"},\"inLanguage\":\"ENH\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/botanico.uclm.es\/en\/project\/trastuzumab-targeted-biodegradable-nanoparticles-for-enhanced-delivery-of-dasatinib-in-her2-metastasic-breast-cancer\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/botanico.uclm.es\/en\/project\/trastuzumab-targeted-biodegradable-nanoparticles-for-enhanced-delivery-of-dasatinib-in-her2-metastasic-breast-cancer\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\/\/botanico.uclm.es\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Projects\",\"item\":\"https:\/\/botanico.uclm.es\/project\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Trastuzumab-targeted biodegradable nanoparticles for enhanced delivery of dasatinib in HER2+ metastasic breast cancer\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/botanico.uclm.es\/#website\",\"url\":\"https:\/\/botanico.uclm.es\/\",\"name\":\"Instituto Bot\u00e1nico\",\"description\":\"Universidad de Castilla-La Mancha\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/botanico.uclm.es\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"ENH\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Trastuzumab-targeted biodegradable nanoparticles for enhanced delivery of dasatinib in HER2+ metastasic breast cancer - Instituto Bot\u00e1nico","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/botanico.uclm.es\/en\/project\/trastuzumab-targeted-biodegradable-nanoparticles-for-enhanced-delivery-of-dasatinib-in-her2-metastasic-breast-cancer\/","og_locale":"en_US","og_type":"article","og_title":"Trastuzumab-targeted biodegradable nanoparticles for enhanced delivery of dasatinib in HER2+ metastasic breast cancer - Instituto Bot\u00e1nico","og_url":"https:\/\/botanico.uclm.es\/en\/project\/trastuzumab-targeted-biodegradable-nanoparticles-for-enhanced-delivery-of-dasatinib-in-her2-metastasic-breast-cancer\/","og_site_name":"Instituto Bot\u00e1nico","article_modified_time":"2022-12-22T16:14:57+00:00","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/botanico.uclm.es\/en\/project\/trastuzumab-targeted-biodegradable-nanoparticles-for-enhanced-delivery-of-dasatinib-in-her2-metastasic-breast-cancer\/","url":"https:\/\/botanico.uclm.es\/en\/project\/trastuzumab-targeted-biodegradable-nanoparticles-for-enhanced-delivery-of-dasatinib-in-her2-metastasic-breast-cancer\/","name":"Trastuzumab-targeted biodegradable nanoparticles for enhanced delivery of dasatinib in HER2+ metastasic breast cancer - Instituto Bot\u00e1nico","isPartOf":{"@id":"https:\/\/botanico.uclm.es\/#website"},"datePublished":"2019-12-19T09:29:38+00:00","dateModified":"2022-12-22T16:14:57+00:00","breadcrumb":{"@id":"https:\/\/botanico.uclm.es\/en\/project\/trastuzumab-targeted-biodegradable-nanoparticles-for-enhanced-delivery-of-dasatinib-in-her2-metastasic-breast-cancer\/#breadcrumb"},"inLanguage":"ENH","potentialAction":[{"@type":"ReadAction","target":["https:\/\/botanico.uclm.es\/en\/project\/trastuzumab-targeted-biodegradable-nanoparticles-for-enhanced-delivery-of-dasatinib-in-her2-metastasic-breast-cancer\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/botanico.uclm.es\/en\/project\/trastuzumab-targeted-biodegradable-nanoparticles-for-enhanced-delivery-of-dasatinib-in-her2-metastasic-breast-cancer\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/botanico.uclm.es\/en\/"},{"@type":"ListItem","position":2,"name":"Projects","item":"https:\/\/botanico.uclm.es\/project\/"},{"@type":"ListItem","position":3,"name":"Trastuzumab-targeted biodegradable nanoparticles for enhanced delivery of dasatinib in HER2+ metastasic breast cancer"}]},{"@type":"WebSite","@id":"https:\/\/botanico.uclm.es\/#website","url":"https:\/\/botanico.uclm.es\/","name":"Instituto Bot\u00e1nico","description":"Universidad de Castilla-La Mancha","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/botanico.uclm.es\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"ENH"}]}},"_links":{"self":[{"href":"https:\/\/botanico.uclm.es\/en\/wp-json\/wp\/v2\/project\/6986"}],"collection":[{"href":"https:\/\/botanico.uclm.es\/en\/wp-json\/wp\/v2\/project"}],"about":[{"href":"https:\/\/botanico.uclm.es\/en\/wp-json\/wp\/v2\/types\/project"}],"author":[{"embeddable":true,"href":"https:\/\/botanico.uclm.es\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/botanico.uclm.es\/en\/wp-json\/wp\/v2\/comments?post=6986"}],"version-history":[{"count":1,"href":"https:\/\/botanico.uclm.es\/en\/wp-json\/wp\/v2\/project\/6986\/revisions"}],"predecessor-version":[{"id":6987,"href":"https:\/\/botanico.uclm.es\/en\/wp-json\/wp\/v2\/project\/6986\/revisions\/6987"}],"wp:attachment":[{"href":"https:\/\/botanico.uclm.es\/en\/wp-json\/wp\/v2\/media?parent=6986"}],"wp:term":[{"taxonomy":"pj-categs","embeddable":true,"href":"https:\/\/botanico.uclm.es\/en\/wp-json\/wp\/v2\/pj-categs?post=6986"},{"taxonomy":"pj-tags","embeddable":true,"href":"https:\/\/botanico.uclm.es\/en\/wp-json\/wp\/v2\/pj-tags?post=6986"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}